Hexabrix and Hypotension - a phase IV clinical study of FDA data

Summary:

Hypotension is reported as a side effect among people who take Hexabrix (ioxaglate meglumine; ioxaglate sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Heparin, and have Cardiac failure.

The phase IV clinical study analyzes which people have Hypotension when taking Hexabrix. It is created by eHealthMe based on reports of 448 people who have side effects when taking Hexabrix from the FDA, and is updated regularly.

What is Hexabrix?

Hexabrix has active ingredients of ioxaglate meglumine; ioxaglate sodium. eHealthMe is studying from 448 Hexabrix users. Check the latest studies of Hexabrix.

What is Hypotension?

Hypotension (abnormally low blood pressure) is found to be associated with 3,360 drugs and 4,755 conditions by eHealthMe. Check the latest studies of Hypotension.

On Jul, 12, 2026

448 people reported to have side effects when taking Hexabrix.
Among them, 71 people (15.85%) have Hypotension.

Among these 71 people:

How long have people been on Hexabrix when they have Hypotension? *

What is the gender of people who have Hypotension when taking Hexabrix? *

female: 26.67 %
male: 73.33 %

What is the age of people who have Hypotension when taking Hexabrix? *

What are other drugs people take besides Hexabrix? *

What are other side effects people have besides Hypotension? *

Bradycardia (abnormally slow heart action): 14 people, 19.72%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 11 people, 15.49%
Nausea (feeling of having an urge to vomit): 10 people, 14.08%
Dyspnea (difficult or laboured breathing): 9 people, 12.68%
Fever: 9 people, 12.68%
Malaise (a feeling of general discomfort or uneasiness): 9 people, 12.68%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 8 people, 11.27%
Rashes (redness): 8 people, 11.27%
Itching: 8 people, 11.27%
Arrhythmias (irregular heartbeat): 6 people, 8.45%

What are the existing conditions these people have? *

Diabetes: 3 people, 4.23%
Cardiomyopathy Acute (emotional or physical stress can cause rapid and severe heart muscle weakness): 3 people, 4.23%
Cardiac Failure: 3 people, 4.23%
General Anaesthesia: 2 people, 2.82%
Catheterisation Cardiac Abnormal: 2 people, 2.82%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 1.41%
Pain: 1 person, 1.41%

* Approximation only. Some reports may have incomplete information.

Do you take Hexabrix and have Hypotension?

- Check whether Hypotension is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hexabrix:

Hexabrix (448 reports)

Hypotension treatments and more:

Hypotension (329,856 reports)

How severe was Hypotension and when was it recovered:

Hypotension in Hexabrix

Expand to all the drugs that have ingredients of ioxaglate meglumine; ioxaglate sodium:

Hypotension and drugs with ingredients of ioxaglate meglumine; ioxaglate sodium

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hexabrix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypotension:

Hypotension (3,360 drugs)

Browse all the conditions that are associated with Hypotension:

Hypotension (4,755 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ioxaglate meglumine; ioxaglate sodium (the active ingredients of Hexabrix) and Hexabrix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.